Clarke Error Grid

From WikiMD's WELLNESSPEDIA

File:Clarkeerrorgrid.gif

== Clarke Error Grid ==

The Clarke Error Grid is a tool used in diabetes management to assess the accuracy of blood glucose monitoring systems. It was developed by Dr. William Clarke and his colleagues in 1987. The grid is a scatter plot that compares the blood glucose readings from a test device to a reference method, typically a laboratory measurement.

Purpose[edit]

The primary purpose of the Clarke Error Grid is to evaluate the clinical significance of the differences between the test device readings and the reference method. It helps to determine whether the discrepancies are likely to lead to inappropriate treatment decisions.

Structure[edit]

The Clarke Error Grid is divided into five zones:

  • **Zone A**: Clinically accurate readings that lead to correct treatment decisions.
  • **Zone B**: Readings that deviate slightly but would not lead to significant clinical consequences.
  • **Zone C**: Readings that could lead to unnecessary treatment.
  • **Zone D**: Readings that could lead to a failure to detect and treat a problem.
  • **Zone E**: Readings that would result in erroneous treatment decisions.

Clinical Significance[edit]

The Clarke Error Grid is widely used in the evaluation of glucometers and other blood glucose monitoring devices. It provides a visual and quantitative method to assess the potential impact of measurement errors on patient care. Devices that produce readings predominantly in Zones A and B are considered clinically acceptable.

History[edit]

The Clarke Error Grid was introduced in a seminal paper published in 1987 by Dr. William Clarke and his team. Since then, it has become a standard tool in the field of diabetes care and has been referenced in numerous studies and guidelines.

Related Tools[edit]

Other tools similar to the Clarke Error Grid include the Parkes Error Grid and the Consensus Error Grid. These tools also aim to evaluate the accuracy and clinical relevance of blood glucose monitoring systems.

See Also[edit]

References[edit]


External Links[edit]

Diabetes
Types
Blood tests
Management
Complications
Advocacy and
organizations
Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Clarke_Error_Grid&oldid=5795667"